All
1.
In vivo evaluation of homeostatic effects of Echis carinatus snake venom in Iran
Hossein Salmanizadeh, Mahdi Babaie, Hossein Zolfagharian Journal of Venomous Animals and Toxins including Tropical Diseases 2013, 19 :3 (27 February 2013)
Abstract | Full text | PDF
2.
Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2
Shi-Hua Li, Xiao-Feng Li, Hui Zhao, Yong-Qiang Deng, Xue-Dong Yu, Shun-Ya Zhu, Tao Jiang, Qing Ye, E-De Qin, Cheng-Feng Qin Virology Journal 2013, 10 :64 (26 February 2013)
Abstract | Provisional PDF
| PubMed
3.
Determinants of vitamin a deficiency in children between 6 months and 2 years of age in Guinea-Bissau
Niels Danneskiold-Samsøe, Ane Bærent Fisker, Mathias Jul Jørgensen, Henrik Ravn, Andreas Andersen, Ibraima Djogo Balde, Christian Leo-Hansen, Amabelia Rodrigues, Peter Aaby, Christine Stabell Benn BMC Public Health 2013, 13 :172 (25 February 2013)
Abstract | Provisional PDF
| PubMed
4.
Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG
Fátima Reyes, Yanely Tirado, Alina Puig, Reinier Borrero, Giselle Reyes, Sonsire Fernández, José Pérez, Ramlah Kadir, Caridad Zayas, Mohd Nor Norazmi, María E Sarmiento, Armando Acosta BMC Immunology 2013, 14 (Suppl 1):S7 (25 February 2013)
Abstract | Full text | PDF
5.
A proteoliposome formulation derived from Bordetella pertussis induces protection in two murine challenge models
Sonsire Fernández, Esther M Fajardo, Aleida Mandiarote, Gemma Año, Maria A Padrón, Michel Acosta, Rubén A Cabrera, Luis A Riverón, Maydelis Álvarez, Kirenia Blaín, Mildrey Fariñas, Daniel Cardoso, Luis G García, Concepción Campa, José L Pérez BMC Immunology 2013, 14 (Suppl 1):S8 (25 February 2013)
Abstract | Full text | PDF
6.
In silico identification of common epitopes from pathogenic mycobacteria
Bárbara de la Caridad Addine Ramírez, Reynel Marrón, Rommel Calero, Mayelin Mirabal, Juan Ramírez, María E Sarmiento, Mohd Nor Norazmi, Armando Acosta BMC Immunology 2013, 14 (Suppl 1):S6 (25 February 2013)
Abstract | Full text | PDF
7.
Evaluation of the humoral immune response and cross reactivity against Mycobacterium tuberculosis of mice immunized with liposomes containing glycolipids of Mycobacterium smegmatis
Reinier Borrero, María de los A García, Liem Canet, Caridad Zayas, Fátima Reyes, Jorge L Prieto, Juan F Infante, María E Lanio, Ramlah Kadir, Yamilé López, María E Sarmiento, Mohd Nor Norazmi, Armando Acosta BMC Immunology 2013, 14 (Suppl 1):S13 (25 February 2013)
Abstract | Full text | PDF
8.
New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity
Beatriz Tamargo, Yanet Márquez, Wendy Ramírez, Bárbara Cedré, Manuel Fresno, Gustavo Sierra BMC Immunology 2013, 14 (Suppl 1):S12 (25 February 2013)
Abstract | Full text | PDF
9.
Evaluation of specific humoral immune response and cross reactivity against Mycobacterium tuberculosis antigens induced in mice immunized with liposomes composed of total lipids extracted from Mycobacterium smegmatis
María de los Angeles García, Reinier Borrero, Reynel Marrón, María E Lanio, Lien Canet, Oscar Otero, Ramlah Kadir, Siti Suraiya, Caridad Zayas, Yamilé López, Mohd Nor Norazmi, Maria E Sarmiento, Armando Acosta BMC Immunology 2013, 14 (Suppl 1):S11 (25 February 2013)
Abstract | Full text | PDF
10.
Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi
Reinaldo Acevedo, Adriana Callicó, Yisabel Aranguren, Caridad Zayas, Yolanda Valdés, Oliver Pérez, Luis García, Valerie A Ferro, José Pérez BMC Immunology 2013, 14 (Suppl 1):S10 (25 February 2013)
Abstract | Full text | PDF
11.
Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B
Caridad Zayas, Domingo González, Reinaldo Acevedo, Judith del Campo, Miriam Lastre, Elizabeth González, Belkis Romeu, Maribel Cuello, Julio Balboa, Osmir Cabrera, Luisa Guilherme, Oliver Pérez BMC Immunology 2013, 14 (Suppl 1):S4 (25 February 2013)
Abstract | Full text | PDF
12.
Highly conserved antigenic epitope regions of hemagglutinin and neuraminidase genes between 2009 H1N1 and seasonal H1N1 influenza: vaccine considerations
Ping Huang, Shouyi Yu, Changyou Wu, Lijun Liang Journal of Translational Medicine 2013, 11 :47 (22 February 2013)
Abstract | Provisional PDF
| PubMed
13.
Safety and reactogenicity of primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Vietnamese infants: a randomised, controlled trial
Tran Ngoc Huu, Nguyen Trong Toan, Ha Manh Tuan, Ho Lu Viet, Pham Le Thanh Binh, Ta-Wen Yu, Fakrudeen Shafi, Ahsan Habib, Dorota Borys BMC Infectious Diseases 2013, 13 :95 (21 February 2013)
Abstract | Provisional PDF
| PubMed
14.
Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda
Benon B Asiimwe, Godwins B Bagyenzi, Willy Ssengooba, Francis Mumbowa, Gerald Mboowa, Anne Wajja, Harriet Mayanja-Kiiza, Philippa M Musoke, Eric Wobudeya, Gunilla Kallenius, Moses L Joloba BMC Infectious Diseases 2013, 13 :88 (18 February 2013)
Abstract | Provisional PDF
| PubMed
15.
Recombinant salmonella-based 4-1BBL vaccine enhances T cell immunity and inhibits the development of colorectal cancer in rats: in vivo effects of vaccine containing 4-1BBL
Jianxin Ye, Ling Li, Yuanting Zhang, Xueguang Zhang, Daming Ren, Weichang Chen Journal of Biomedical Science 2013, 20 :8 (17 February 2013)
Abstract | Provisional PDF
| PubMed
16.
PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity
Patricio Oyarzún, Jonathan J Ellis, Mikael Bodén, Bo¿tjan Kobe BMC Bioinformatics 2013, 14 :52 (14 February 2013)
Abstract | Provisional PDF
| PubMed
17.
Development of one-step quantitative reverse transcription PCR for the rapid detection of flaviviruses
Pranav Patel, Olfert Landt, Marco Kaiser, Oumar Faye, Tanja Koppe, Ulrich Lass, Amadou A Sall, Matthias Niedrig Virology Journal 2013, 10 :58 (14 February 2013)
Abstract | Provisional PDF
| PubMed
18.
An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity. Running title: Lassa vaccine in SIV-positive macaques
Juan C Zapata, Bhawna Poonia, Joseph Bryant, Harry Davis, Eugene Ateh, Lanea George, Oswald Crasta, Yan Zhang, Tom Slezak, Crystal Jaing, C David Pauza, Marco Goicochea, Dmitry Moshkoff, Igor S Lukashevich, Maria S Salvato Virology Journal 2013, 10 :52 (12 February 2013)
Abstract | Provisional PDF
| PubMed
19.
Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis
Joel K Kelso, Nilimesh Halder, George J Milne BMC Infectious Diseases 2013, 13 :81 (11 February 2013)
Abstract | Provisional PDF
| PubMed
20.
Chikungunya and the eye: a review
Padmamalini Mahendradas, Kavitha Avadhani, Rohit Shetty Journal of Ophthalmic Inflammation and Infection 2013, 3 :35 (11 February 2013)
Abstract | Full text | PDF
21.
Antigen dose and humoral immune response correspond with protection for inactivated infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L)
Hetron Mweemba Munang¿andu, Børge Nilsen Fredriksen, Stephen Mutoloki, Roy Ambli Dalmo, Øystein Evensen Veterinary Research 2013, 44 :7 (11 February 2013)
Abstract | Provisional PDF
| PubMed
22.
Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles
Shu-Chun Chuang, Jing-Chun Ko, Chaio-Ping Chen, Jia-Tze Du, Chung-Da Yang Parasites & Vectors 2013, 6 :34 (11 February 2013)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
We have successfully encapsulated rSAG1 with poly (lactide-co-glycolide) (PLG) polymers to produce stable microparticles that can induce long-lasting immunity to protect BALB/c mice against Toxoplasma gondii tachyzoite infection. Image: PLG-encapsulated rSAG1 microparticles.
23.
Knowledge translation of the HELPinKIDS clinical practice guideline for managing childhood vaccination pain: usability and knowledge uptake of educational materials directed to new parents
Anna Taddio, Vibhuti Shah, Eman Leung, Jane Wang, Chaitya Parikh, Sarah Smart, Ross Hetherington, Moshe Ipp, Rebecca Pillai Riddell, Michael Sgro, Aleksandra Jovicic, Linda Franck BMC Pediatrics 2013, 13 :23 (8 February 2013)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
An educational pamphlet and video effectively increase parental knowledge about managing vaccination pain in children, suggesting that these educational tools may influence parent behaviors during infant vaccinations in clinical settings.
24.
A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18--26 years
Cristina Giambi, Serena Donati, Francesca Carozzi, Stefania Salmaso, Silvia Declich, Marta L Atti, Guglielmo Ronco, Maria P Alibrandi, Silvia Brezzi, Natalina Collina, Daniela Franchi, Amedeo Lattanzi, Maria C Minna, Roberto Nannini, Elena Barretta, Elena Burroni, Anna Gillio-Tos, Vincenzo Macallini, Paola Pierotti, Antonino Bella BMC Infectious Diseases 2013, 13 :74 (7 February 2013)
Abstract | Provisional PDF
| PubMed
25.
Rome consensus conference - statement; Human Papilloma Virus diseases in males
Andrea Lenzi, Vincenzo Mirone, Vincenzo Gentile, Riccardo Bartoletti, Vincenzo Ficarra, Carlo Foresta, Luciano Mariani, Sandra Mazzoli, Saverio G Parisi, Antonio Perino, Mauro Picardo, Carla Maria Zotti BMC Public Health 2013, 13 :117 (7 February 2013)
Abstract | Provisional PDF
| PubMed